CD274 and non-small cell lung carcinoma: PD-L2 expression significantly correlated with PD-L1 expression in different NSCLC gene expression datasets, and both PD-L1 and PD-L2 expression were associated with specific gene signatures, suggesting a potential role for PD-L2 and these gene expression biomarkers in predicting clinical responses to immune checkpoint blockade [201].